Avai Bio (AVAI) Other Accumulated Expenses (2018 - 2026)

Avai Bio has disclosed Other Accumulated Expenses across 8 years of filings, most recently posting $802972.0 for Q2 2026.

• In Q2 2026, Other Accumulated Expenses rose 27.07% year-over-year to $802972.0; the TTM figure through Jun 2026 stood at $802972.0 (up 27.07% YoY), while the FY2026 annual figure was $744420.0, up 45.37% from the prior year.
• Other Accumulated Expenses came in at $802972.0 for Q2 2026 at Avai Bio, up from $744420.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $802972.0 in Q2 2026 to a low of $2816.0 in Q1 2022.
• Average Other Accumulated Expenses over 5 years is $548886.4, with a median of $633391.5 recorded in 2024.
• Year-over-year, Other Accumulated Expenses surged 8572.51% in 2023 and declined 0.47% in 2025.
• Over 5 years, Other Accumulated Expenses stood at $2816.0 in 2022, then surged by 8572.51% to $244218.0 in 2023, then surged by 121.57% to $541123.0 in 2024, then increased by 29.0% to $698034.0 in 2025, then grew by 15.03% to $802972.0 in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $802972.0 in Q2 2026, $744420.0 in Q1 2026, and $698034.0 in Q4 2025.